2016
DOI: 10.1158/0008-5472.can-15-1492
|View full text |Cite
|
Sign up to set email alerts
|

Deguelin Analogue SH-1242 Inhibits Hsp90 Activity and Exerts Potent Anticancer Efficacy with Limited Neurotoxicity

Abstract: The Hsp90 facilitates proper folding of signaling proteins associated with cancer progression, gaining attention as a target for therapeutic intervention.

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
46
0
1

Year Published

2016
2016
2023
2023

Publication Types

Select...
5
1
1

Relationship

1
6

Authors

Journals

citations
Cited by 46 publications
(51 citation statements)
references
References 50 publications
(64 reference statements)
4
46
0
1
Order By: Relevance
“…We first observed that 1 treatment did not notably attenuate the expression of Hsp90 protein. In agreement with earlier studies474849, the expression of Hsp70 increased in a time-dependent manner, as an established marker for HSR after Hsp90 inhibition, while surprisingly the expression of HSF 1 protein was attenuated with 1 treatment in Molt 4 cells. As expected, the suppression of Hsp90 client proteins was observed, including p70 S6k , NFκB, Raf-1, p-GSK3β, MEK 1 and XIAP (pro-apoptotic protein), MDM 2 and Rb2 (oncoprotein), and CDK4 (cell cycle regulatory protein), HIF 1 and HSF1 (transcription factor) (Fig.…”
Section: Resultssupporting
confidence: 92%
See 2 more Smart Citations
“…We first observed that 1 treatment did not notably attenuate the expression of Hsp90 protein. In agreement with earlier studies474849, the expression of Hsp70 increased in a time-dependent manner, as an established marker for HSR after Hsp90 inhibition, while surprisingly the expression of HSF 1 protein was attenuated with 1 treatment in Molt 4 cells. As expected, the suppression of Hsp90 client proteins was observed, including p70 S6k , NFκB, Raf-1, p-GSK3β, MEK 1 and XIAP (pro-apoptotic protein), MDM 2 and Rb2 (oncoprotein), and CDK4 (cell cycle regulatory protein), HIF 1 and HSF1 (transcription factor) (Fig.…”
Section: Resultssupporting
confidence: 92%
“…It was reported that Hsp90 facilitates the proper folding of signaling proteins associated with cancer progression, tumor angiogenesis and therapy resistance by functioning as molecular chaperone, gaining attention as a target for therapeutic intervention474853. A growing body of evidence indicates that the accumulation of unfolding/misfolding proteins by the suppression of Hsp90 function assists several stresses, including ER stress overload, the ROS over-generation, and a functional disorder of the intracellular proteins, ultimately leading to ER stress-induced apoptosis, if unfolding is overwhelming54555657.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Our current study demonstrates for the first time that deguelin, a rotenoid derived from Mundulea sericea (Willd) [15][16][17] with a chemical structure distinct from CQ, is a novel late-stage autophagy inhibitor. Previous reports have shown that deguelin inhibits the survival of various cancer cells through mechanisms including DNA damage induction, reduced expression of DNA repair genes, inhibition of vasculogenic function, and blockage of anti-apoptotic pathways [13,25,26].…”
Section: Discussionmentioning
confidence: 77%
“…Previous studies have shown that deguelin induces apoptosis in cancer cells by targeting the AMPK and PI3K/Akt pathway [16,17]. Furthermore, deguelin inhibits the growth and metastasis of pancreatic cancer cells both in vivo and in vitro [18].…”
Section: Introductionmentioning
confidence: 98%